» Articles » PMID: 22454888

Bioavailability of Digoxin from Rapidly Dissolving Preparations

Overview
Specialty Pharmacology
Date 2012 Mar 29
PMID 22454888
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

1 Intestinal absorption of digoxin was assessed by determination of peak plasma concentrations, areas under plasma concentration curves over 80 h, and 10 day urinary excretion. Absorption was equal after ingestion of single doses of standard Lanoxin (Wellcome) tablets, tablets and capsules of ultra-rapid dissolution rate material, or an oral solution of digoxin in water. 2 Mean plasma concentrations and dosage-interval urinary excretion were highly similar during 14 day courses of either Lanoxin or ultra-rapid dissolution tablets. Increased bioavailability does not result from encapsulation of solid dosage presentations, nor from increasing tablet dissolution rate beyond 75% in 15 minutes. 3 Fourteen day courses of tablets of slow dissolution rate produced lower and less consistent mean plasma concentrations and urinary excretion. Slow dissolution rates are associated with greater individual variability in absorption.

Citing Articles

A standard approach to compiling clinical pharmacokinetic data.

Sheiner L, Benet L, Pagliaro L J Pharmacokinet Biopharm. 1981; 9(1):59-127.

PMID: 7014827 DOI: 10.1007/BF01059343.


Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?.

Dobbs R, ONeill C, Deshmukh A, Nicholson P, Dobbs S Clin Pharmacokinet. 1991; 20(3):175-93.

PMID: 2025980 DOI: 10.2165/00003088-199120030-00001.


Prediction of digoxin dose requirements.

Dobbs S, Mawer G Clin Pharmacokinet. 1977; 2(4):281-91.

PMID: 902448 DOI: 10.2165/00003088-197702040-00004.

References
1.
Lindenbaum J, Butler Jr V, Murphy J, CRESSWELL R . Correlation of digoxin-tablet dissolution-rate with biological availability. Lancet. 1973; 1(7814):1215-7. DOI: 10.1016/s0140-6736(73)90528-x. View

2.
Greenblatt D, Duhme D, Koch-Weser J, Smith T . Evaluation of digoxin bioavailability in single-dose studies. N Engl J Med. 1973; 289(13):651-4. DOI: 10.1056/NEJM197309272891302. View

3.
Huffman D, AZARNOFF D . Absorption of orally given digoxin preparations. JAMA. 1972; 222(8):957-60. View

4.
CROSLAND-TAYLOR P, Keeling D, Cromie B . A TRIAL OF SLOW-RELEASE TABLETS OF FERROUS SULPHATE. Curr Ther Res Clin Exp. 1965; 7:244-8. View

5.
Manninen V, Melin J, Hartel G . Serum-digoxin concentrations during treatment with different preparations. Lancet. 1971; 2(7730):934-5. DOI: 10.1016/s0140-6736(71)92560-8. View